[Breaking news] [LAUNCH] What causes (rare) cholestasis in paediatric patients? Discover it through diagnostic algorithms, clinical cases and much more on this new website dedicated to cholestasis in paediatric patients.
We all at CTRS are extremely sad to announce the passing of Christian CAILLIOT, Director of R&D. For all of us, it was an immense privilege to have the opportunity to work with him throughout these many years. Rigorous, professional and creative, he has been one of the crucial players in making CTRS what it […]
CTRS is proud to work in rare diseases area and make a difference for patients. Despite all the challenges that represent rare diseases, it is crucial to always maintain and improve efforts to enhance high level research, development and access to treatments which are close to the unique. Encouraging rare disease recognition is essential to […]
For the second year in a row, CTRS is proud to be part of the TOP 500 of Growth Champions 2021 ! This year we reach the 380 spot.
We are proud to announce a partnership with Unicancer aimed to support the development of high potential molecules in the treatment of rare cancers. We hope this partnership will facilitate the access of new therapies to patients.
Antoine Ferry, CEO of CTRS, will be present on the YouTube chanel of Fondation Maladies Rares (Rare Diseases Foundation) to speack on the repositioning drugs in rare diesaeses. To watch the show: (1) Web-émission#4 : “Le repositionnement de médicaments” – YouTube